Clinical Trial Update: An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing concurrent chemoradiation with weekly cisplatin versus three-weekly cisplatin in locally advanced head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 4 | Status: COMPLETED